Report Detail
Dynamics in Post-pandemic Global HPAPI (High Potency Active Pharmaceutical Ingredients) Industry: Supply and Demand, Markets and Prices 2021-2027
- RnM4305190 |
- 13 April, 2021 |
- Global |
- 135 Pages |
- GRD Survey |
- Pharma & Healthcare
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global HPAPI (High Potency Active Pharmaceutical Ingredients) market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global HPAPI (High Potency Active Pharmaceutical Ingredients) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Innovative HPAPI
Generic HPAPI
Segmented by End User/Segment
Captive HPAPI
Merchant HPAPI
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Thermofisher Scientific
Teva Pharmaceutical
Pfizer
Novasep
Merck
Lonza
Dr. Reddy’S
Dishman
Cambrex
Alkermes
Table of Contents
1 Product Introduction and Overview
- 1.1 Product Definition
- 1.2 Product Specification
- 1.3 Global Market Overview
- 1.3.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Status and Forecast (2016-2027)
- 1.3.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Value CAGR by Region
- 1.4 Market Drivers, Inhibitors
- 1.4.1 Market Drivers
- 1.4.2 Market Inhibitors
- 1.4.3 COVID-19 Impact Analysis
2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Supply by Company
- 2.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume by Company
- 2.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Value by Company
- 2.3 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Price by Company
- 2.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Production Location and Sales Area of Main Manufacturers
- 2.5 Trend of Concentration Rate
3 Global and Regional HPAPI (High Potency Active Pharmaceutical Ingredients) Market Status by Category
- 3.1 HPAPI (High Potency Active Pharmaceutical Ingredients) Category Introduction
- 3.1.1 Innovative HPAPI
- 3.1.2 Generic HPAPI
- 3.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market by Category
- 3.2.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume by Category (2016-2021)
- 3.2.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Value by Category (2016-2021)
- 3.2.3 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Price by Category (2016-2021)
- 3.3 North America: by Category
- 3.4 Europe: by Category
- 3.5 Asia Pacific: by Category
- 3.6 Central & South America: by Category
- 3.7 Middle East & Africa: by Category
4 Global and Regional HPAPI (High Potency Active Pharmaceutical Ingredients) Market Status by End User/Segment
- 4.1 HPAPI (High Potency Active Pharmaceutical Ingredients) Segment by End User/Segment
- 4.1.1 Captive HPAPI
- 4.1.2 Merchant HPAPI
- 4.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market by End User/Segment
- 4.2.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume by End User/Segment (2016-2021)
- 4.2.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Value by End User/Segment (2016-2021)
- 4.2.3 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Price by End User/Segment (2016-2021)
- 4.3 North America: by End User/Segment
- 4.4 Europe: by End User/Segment
- 4.5 Asia Pacific: by End User/Segment
- 4.6 Central & South America: by End User/Segment
- 4.7 Middle East & Africa: by End User/Segment
5 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Status by Region
- 5.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market by Region
- 5.1.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume by Region
- 5.1.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Value by Region
- 5.2 North America HPAPI (High Potency Active Pharmaceutical Ingredients) Market Status
- 5.3 Europe HPAPI (High Potency Active Pharmaceutical Ingredients) Market Status
- 5.4 Asia Pacific HPAPI (High Potency Active Pharmaceutical Ingredients) Market Status
- 5.5 Central & South America HPAPI (High Potency Active Pharmaceutical Ingredients) Market Status
- 5.6 Middle East & Africa HPAPI (High Potency Active Pharmaceutical Ingredients) Market Status
6 North America HPAPI (High Potency Active Pharmaceutical Ingredients) Market Status
- 6.1 North America HPAPI (High Potency Active Pharmaceutical Ingredients) Market by Country
- 6.1.1 North America HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume by Country (2016-2021)
- 6.1.2 North America HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Value by Country (2016-2021)
- 6.2 United States
- 6.3 Canada
- 6.4 Mexico
7 Europe HPAPI (High Potency Active Pharmaceutical Ingredients) Market Status
- 7.1 Europe HPAPI (High Potency Active Pharmaceutical Ingredients) Market by Country
- 7.1.1 Europe HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume by Country (2016-2021)
- 7.1.2 Europe HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Value by Country (2016-2021)
- 7.2 Germany
- 7.3 France
- 7.4 UK
- 7.5 Italy
- 7.6 Russia
- 7.7 Spain
8 Asia Pacific HPAPI (High Potency Active Pharmaceutical Ingredients) Market Status
- 8.1 Asia Pacific HPAPI (High Potency Active Pharmaceutical Ingredients) Market by Country
- 8.1.1 Asia Pacific HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume by Country (2016-2021)
- 8.1.2 Asia Pacific HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Value by Country (2016-2021)
- 8.2 China
- 8.3 Japan
- 8.4 Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australasia
9 Central & South America HPAPI (High Potency Active Pharmaceutical Ingredients) Market Status
- 9.1 Central & South America HPAPI (High Potency Active Pharmaceutical Ingredients) Market by Country
- 9.1.1 Central & South America HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume by Country (2016-2021)
- 9.1.2 Central & South America HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Value by Country (2016-2021)
- 9.2 Brazil
- 9.3 Argentina
- 9.4 Colombia
10 Middle East & Africa HPAPI (High Potency Active Pharmaceutical Ingredients) Market Status
- 10.1 Middle East & Africa HPAPI (High Potency Active Pharmaceutical Ingredients) Market by Country
- 10.1.1 Middle East & Africa HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume by Country (2016-2021)
- 10.1.2 Middle East & Africa HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Value by Country (2016-2021)
- 10.2 Iran
- 10.3 Israel
- 10.4 Turkey
- 10.5 South Africa
- 10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
- 11.1 Supply Chain Analysis
- 11.2 Production Process Chart Analysis
- 11.3 Raw Materials and Key Suppliers Analysis
- 11.3.1 Raw Materials Introduction
- 11.3.2 Raw Materials Key Suppliers List
- 11.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Manufacturing Cost Analysis
- 11.5 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Channel and Distributors Analysis
- 11.5.1 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Channel
- 11.5.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Distributors
- 11.6 HPAPI (High Potency Active Pharmaceutical Ingredients) Downstream Major Buyers
12 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Forecast by Category and by End User/Segment
- 12.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume and Sales Value Forecast (2022-2027)
- 12.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Forecast by Category
- 12.2.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume Forecast by Category
- 12.2.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Value Forecast by Category
- 12.2.3 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Price Forecast by Category
- 12.3 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Forecast by End User/Segment
- 12.3.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume Forecast by End User/Segment
- 12.3.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Value Forecast by End User/Segment
- 12.3.3 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Price Forecast by End User/Segment
13 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Forecast by Region/Country
- 13.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Forecast by Region (2022-2027)
- 13.1.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume Forecast by Region (2022-2027)
- 13.1.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Value Forecast by Region (2022-2027)
- 13.2 North America Market Forecast
- 13.3 Europe Market Forecast
- 13.4 Asia Pacific Market Forecast
- 13.5 Central & South America Market Forecast
- 13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
- 14.1 Thermofisher Scientific
- 14.1.1 Company Information
- 14.1.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 14.1.3 Thermofisher Scientific HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.1.4 SWOT Analysis
- 14.2 Teva Pharmaceutical
- 14.2.1 Company Information
- 14.2.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 14.2.3 Teva Pharmaceutical HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.2.4 SWOT Analysis
- 14.3 Pfizer
- 14.3.1 Company Information
- 14.3.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 14.3.3 Pfizer HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.3.4 SWOT Analysis
- 14.4 Novasep
- 14.4.1 Company Information
- 14.4.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 14.4.3 Novasep HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.4.4 SWOT Analysis
- 14.5 Merck
- 14.5.1 Company Information
- 14.5.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 14.5.3 Merck HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.5.4 SWOT Analysis
- 14.6 Lonza
- 14.6.1 Company Information
- 14.6.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 14.6.3 Lonza HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.6.4 SWOT Analysis
- 14.7 Dr. Reddy’S
- 14.7.1 Company Information
- 14.7.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 14.7.3 Dr. Reddy’S HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.7.4 SWOT Analysis
- 14.8 Dishman
- 14.8.1 Company Information
- 14.8.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 14.8.3 Dishman HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.8.4 SWOT Analysis
- 14.9 Cambrex
- 14.9.1 Company Information
- 14.9.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 14.9.3 Cambrex HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.9.4 SWOT Analysis
- 14.10 Alkermes
- 14.10.1 Company Information
- 14.10.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 14.10.3 Alkermes HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.10.4 SWOT Analysis
15 Conclusion
16 Methodology
Summary:
Get latest Market Research Reports on HPAPI (High Potency Active Pharmaceutical Ingredients). Industry analysis & Market Report on HPAPI (High Potency Active Pharmaceutical Ingredients) is a syndicated market report, published as Dynamics in Post-pandemic Global HPAPI (High Potency Active Pharmaceutical Ingredients) Industry: Supply and Demand, Markets and Prices 2021-2027. It is complete Research Study and Industry Analysis of HPAPI (High Potency Active Pharmaceutical Ingredients) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
